Continuous hemofiltration is usually regarded as a safe method for controlling fluid overload in neonates presenting acute renal failure. We considered that continuous hemodiafiltration with a hemofilter type especially designed for use in the neonatal period could improve urea removal as compared with hemofiltration. Continuous arteriovenous hemofiltration (CAVH) and hemodiafiltration (CAVHD) were consecutively performed on 7 anesthetized adult rabbits which were given an urea infusion. The hemofilter was a 800-cm2 polysulfone model (Amicon Minifilter Plus). Mean values for physiological and operational parameters were comparable during CAVH and CAVHD, i.e., mean blood pressure (69.6 ± 14.9 and 70 ± 13.1 mm Hg, respectively), arterial oncotic pressure (16.0 ± 2.4 and 16.0 ± 1.7 mm Hg), hematocrit (36.2 ± 5.8 and 36.7 ± 4.4%), protein plasma level (38.9 ± 7.0 and 39.0 ± 6.4 g/l), urea plasma level (20.6 ± 6.5 and 19.9 ± 7.0 mmol/l), plasma flow in the hemofilter (7.89 ± 8.48 and 7.12 ± 3.08 ml/min), and ultrafiltrate rate (1.17 ± 0.49 and 1.73 ± 0.78 ml/min). CAVHD allowed a significant increase in urea clearance (4.74 ± 4.51 ml/min) as compared with CAVH (1.23 ± 0.81 ml/min). These experimental results suggest that CAVHD usefulness should be assessed in neonates presenting acute renal failure.

Keywords:
Uremia, Hemofiltration, Hemodiafiltration, Acute renal failure, Newborn infant
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.